Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PCSA | Common Stock | Gift | $0 | -7K | -8.98% | $0.00 | 70.9K | Mar 31, 2022 | Direct | F1 |
holding | PCSA | Common Stock | 66.3K | Nov 1, 2021 | by Elion Oncology, Inc. | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PCSA | Restricted Stock Units | Award | $0 | +4.29K | +18.81% | $0.00 | 27.1K | Nov 1, 2021 | Common Stock | 4.29K | $0.00 | Direct | F2 |
transaction | PCSA | Restricted Stock Units | Award | $0 | +10.7K | +39.59% | $0.00 | 37.8K | Mar 31, 2022 | Common Stock | 10.7K | $0.00 | Direct | F2 |
Id | Content |
---|---|
F1 | Shares previously reported as indirectly held by Elion Oncology were transferred to the reporting person's direct holdings in an transaction exempt from Section 16 reporting. |
F2 | Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death. |